Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

Study ID: NCT07037004
Start Date: 2026-05-04
End Date: 2027-05-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

62

Intervention / Treatment

Biospecimen Collection

Clostridium butyricum CBM588 Strain

Computed Tomography

Pembrolizumab

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Study ID: NCT07142252
Start Date: 2025-11-13
End Date: 2029-05-13
Study Type

Interventional

Study Phase

Phase2

No. of Participants

66

Intervention / Treatment

Rezpegaldesleukin

Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Source: clinicaltrials.gov

Share:
Add to list

Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections

Study ID: NCT07220915
Start Date: 2025-12
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

360

Intervention / Treatment

Panzyga, 10% Intravenous Solution

Placebo

Sponsor

Octapharma

Source: clinicaltrials.gov

Share:
Add to list

Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib

Study ID: NCT06983691
Start Date: 2026-01
End Date: 2026-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

26

Intervention / Treatment

Patient Navigation Program

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer

Study ID: NCT07124611
Start Date: 2026-01-10
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Interview

Nutritional Therapy

Physical Therapy

Psychosocial Care

Administration Questionnaire

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

ENA-001 for Post Operative Respiratory Depression (PORD)

Study ID: NCT06137638
Start Date: 2026-03-15
End Date: 2026-12-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

ENA-001

Sponsor

Enalare Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

Study ID: NCT07223671
Start Date: 2025-11-12
End Date: 2026-03-19
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

Repotrectinib

Metformin

Digoxin

Rosuvastatin

Bupropion

Flurbiprofen

Omeprazole

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications

Study ID: NCT06649864
Start Date: 2026-02
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Autologous adipose derived mesenchymal stromal cells (AMSC)

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Implementation of PrEP Care Among Women in Family Planning Clinics

Study ID: NCT06335121
Start Date: 2025-12
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment

POWER Up strategies -

Sponsor

Rush University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Research Investigating Drug Effects-2 (RiDE-2)

Study ID: NCT06758596
Start Date: 2026-07-15
End Date: 2031-06
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

144

Intervention / Treatment

Placebo Oral Capsule

THC

Sponsor

University of Illinois at Chicago

Source: clinicaltrials.gov

Share:
Add to list